Jeremy Peter Scott

Title: Jeremy Peter Scott: Innovator in Renin Inhibitors

Introduction

Jeremy Peter Scott is a notable inventor based in Herford, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as renin inhibitors. His work is crucial in addressing cardiovascular events and renal insufficiency.

Latest Patents

Jeremy holds a patent for "3,4-substituted piperidine derivatives as renin inhibitors." This invention relates to 3,4-substituted piperidinyl-based renin inhibitor compounds that bear at the 4-position oxopyridine. The patent outlines the formula (I) and discusses pharmaceutical compositions containing these compounds, emphasizing their therapeutic use in treating cardiovascular events and renal insufficiency. He has 1 patent to his name.

Career Highlights

Jeremy is currently employed at Actelion Pharmaceuticals Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His expertise in developing new compounds has positioned him as a valuable asset in his field.

Collaborations

Throughout his career, Jeremy has collaborated with talented individuals such as Austin Chih-Yu Chen and Daniel Dube. These collaborations have likely enhanced the scope and impact of his work in pharmaceutical research.

Conclusion

Jeremy Peter Scott is a distinguished inventor whose work in renin inhibitors has the potential to significantly improve treatment options for cardiovascular and renal conditions. His contributions to the field are noteworthy and reflect his commitment to advancing medical science.